Recommended screening for retinopathy in patients on hydroxychloroquine

Low-risk patientsPatients with risk factorsa
Initial screeningWithin first year of therapyWithin first year of therapy
Repeat screeningAfter 5 years of therapy, then annuallyAnnually
  • a Higher medical dose, decreased renal function, tamoxifen use, or macular disease.

  • Based on information in references 27 and 28.